STUDY

Lamisil cured toenail fungus in about 3 of 4 people, far more often than Sporanox

“Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.” Evans EG, Sigurgeirsson B. BMJ. April 1999

Evans EG, Sigurgeirsson B · BMJ · April 1999

Randomized controlled trialNail FungusTerbinafineItraconazole
The finding

In a 72-week trial of 496 people with toenail fungus, daily terbinafine cleared the fungus in about 76% to 81% of people, compared with 38% to 49% on itraconazole pulses.

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Randomized, double-blind, and double-dummy. A random process decided who got which medicine. Everyone took two sets of pills, one real and one dummy, so neither patients nor doctors knew which drug was real.
At a glance

Who was studied and for how long

People
496
Adults 18 to 75
Length
72 weeks
Fungus tested at the end
Condition
Toenail fungus
Confirmed by a lab test
Compared
Terbinafine vs itraconazole
12-week and 16-week courses
Where
35 clinics in 6 European countries
Multicenter
What they did

How the study worked

496 peopletoenail fungusRANDOMSPLITTerbinafineDaily pills12 or 16 weeksItraconazoleOne week in four12 or 16 weeksMEASURED ATWeek 72by lab test496 peopletoenail fungusRANDOMSPLITTerbinafineDaily pills · 12 or 16 weeksItraconazoleOne week in four · 12 or 16 weeksMEASURED ATWeek 72by lab test
1. Split at random496 adults with lab-confirmed toenail fungus were randomly put in four groups.
2. Two drugs, two lengthsTwo groups took terbinafine every day for 12 or 16 weeks. Two took itraconazole one week out of every four, for 12 or 16 weeks.
3. Lab test at 72 weeksThe main result was a negative fungus test on a nail sample.
What they found

The results

TerbinafineItraconazole

Fungus gone, 12-week courses

Negative lab test at week 72

Terbinafine
75.7%
Itraconazole
38.3%
Difference unlikely to be chance (p < 0.0001)

Fungus gone, 16-week courses

Negative lab test at week 72

Terbinafine
80.8%
Itraconazole
49.1%
Difference unlikely to be chance (p < 0.0001)
Terbinafine beat itraconazole in both course lengths, and the gaps were far too large to be luck. The study also said other clinical measures favored terbinafine, and side effects were similar between the drugs.
How much to trust it

Strengths and limits

Strengths

  • Randomized and double-blind
  • Large: 496 people at 35 clinics
  • Used a lab test, not only how the nail looked
  • Long follow-up of 72 weeks

Limits

  • The main result is a lab test, which is not the same as a fully clear-looking nail
  • Itraconazole was tested as pulse dosing only
  • Older study: 1999
  • Fungus can come back over time, and this report covers 72 weeks
High confidence. A large, double-blind randomized trial with a clear, lab-based result.
What it means for you

The takeaway

Terbinafine did better

For toenail fungus, a daily terbinafine course cured more people than itraconazole pulses in this trial. Terbinafine is usually the first oral choice for this reason.

Oral antifungals need a doctor's prescription and sometimes blood tests. Some people cannot take them because of other medicines or liver problems.

Pages that cite this study

Read more on Dermapedia

Condition
Nail Fungus
Medication
Terbinafine
Medication
Itraconazole
Terms in this study

Words worth knowing

Onychomycosis

The medical name for nail fungus.

Mycological cure

A negative lab test, with no fungus found on a nail sample.

Pulse therapy

Taking a medicine for short bursts, with breaks in between, instead of every day.

Double-blind

Neither the people in the study nor the doctors measuring results knew who got which treatment. This keeps hopes and expectations from coloring the results.

Double-dummy

Each person took one real drug and one matching dummy for the other drug, so no one could tell which was real.

Original source

Evans EG, Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group. BMJ. 1999;318(7190):1031–1035.

PMID 10205099